Work

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient

Year: 2013

Type: article

Abstract: Autoimmune liver disease management goals are primarily slowing disease progression and symptomatic treatment. There are few options for curative medical management other than transplant for a spectrum of autoimmune liver disease that encompasses autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis as well as their overlap syndromes. These diseases are managed primarily with immunosuppressive therapy. Herein, we review the current literature, detailing the promise and pitfalls of the recommended immunosuppressive therapy for these challenging diseases.

Source: Pharmaceuticals

DOI: 10.3390/ph7010018

Authors: Anita Abhyankar, Elliot Tapper, Alan Bonder

Institutions: Tufts University, St. Elizabeth's Medical Center, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Liver Diseases and Immunity

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,499